Legal Representation
Attorney
Eric Fingerhut
USPTO Deadlines
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 2, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jan 1, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| May 30, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 26, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 26, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 26, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 29, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 4, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 4, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 14, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 1, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 31, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 31, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 31, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 22, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 22, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 22, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 22, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 18, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 15, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Chemical, biochemical, biological and biotechnical preparations, namely, antibodies, bi- and multispecific antibodies and fragments thereof, in the nature of monoclonal antibodies, their derivatives or conjugates for in vivo or in vitro scientific and industrial research and development related to diseases; active chemical ingredients for use in the manufacture of pharmaceutical preparations for treating cancer, infectious diseases, and autoimmune diseases
Class 005
Pharmaceutical and veterinary preparations that contain antibodies, and bi- and multi-specific antibodies and fragments, including monoclonal antibodies, their derivatives or conjugates, for use to treat cancer, infectious diseases, and autoimmune diseases
Class 042
Medical and biological research, in particular research into antibodies and bi- and multispecific antibodies or fragments, including monoclonal antibodies, their derivatives or conjugates, and the development of pharmaceutical products based on antibodies and bi- and multispecific antibodies or fragments, including monoclonal antibodies, their derivatives or conjugates; Chemical analysis
Classification
International Classes
001
005
042